Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the …

OA Cornely, A Alastruey-Izquierdo, D Arenz… - The Lancet infectious …, 2019 - thelancet.com
Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus …

K Ahmadikia, SJ Hashemi, S Khodavaisy, MI Getso… - Mycoses, 2021 - Wiley Online Library
Acute respiratory distress syndrome is a common complication of severe viral pneumonia,
such as influenza and COVID‐19, that requires critical care including ventilatory support …

Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran

F Pakdel, K Ahmadikia, M Salehi, A Tabari, R Jafari… - Mycoses, 2021 - Wiley Online Library
Purpose The aim of the study was to report clinical features, contributing factors and
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

F Tissot, S Agrawal, L Pagano, G Petrikkos… - …, 2016 - pmc.ncbi.nlm.nih.gov
The European Conference on Infections in Leukemia (ECIL) provides recommendations for
diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various …

Mucormycosis

G Reid, JP Lynch III, MC Fishbein… - Seminars in respiratory …, 2020 - thieme-connect.com
Mucormycosis is an infection caused by a group of filamentous molds within the order
Mucorales. Infections may result from ingestion of contaminated food, inhalation of spores …

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric …

AH Groll, E Castagnola, S Cesaro, JH Dalle… - The Lancet …, 2014 - thelancet.com
Invasive opportunistic fungal diseases (IFDs) are important causes of morbidity and mortality
in paediatric patients with cancer and those who have had an allogeneic haemopoietic stem …

ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

A Alanio, PM Hauser, K Lagrou… - Journal of …, 2016 - academic.oup.com
Abstract The Fifth European Conference on Infections in Leukaemia (ECIL-5) convened a
meeting to establish evidence-based recommendations for using tests to diagnose …

Mucormycoses

D Farmakiotis, DP Kontoyiannis - Infectious Disease Clinics, 2016 - id.theclinics.com
The term zygomycosis has been commonly used to describe invasive fungal infections (IFI)
by the Zygomycetes, a term formerly used to describe molds with aseptate or pauciseptate …

[HTML][HTML] Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French …

L Millon, R Herbrecht, F Grenouillet, F Morio… - Clinical Microbiology …, 2016 - Elsevier
The main objective of this study was to assess the diagnostic performance of a set of three
Mucorales quantitative PCR assays in a retrospective multicentre study. Mucormycosis …

Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic

A Sharma, A Goel - Folia Microbiologica, 2022 - Springer
Mucormycosis is a deadly opportunistic disease caused by a group of fungus named
mucormycetes. Fungal spores are normally present in the environment and the immune …